Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

January
06
2022

Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference

Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14 BOCA RATON, Fla. , Jan. 06, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing…

January
05
2022

Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference

Expects profitability for the 2021 fourth quarter and full year Physician KOL presentation at the Winter Clinical to highlight the TransDermal Infusion System™ BOCA RATON, Fla., Jan. 05, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS),…

December
17
2021

The Alternative Skin Cancer Treatment

If you’ve been diagnosed with skin cancer, you might be wondering what your options are when it comes to your treatment. For nearly 90 years, Mohs surgery has been the procedure of choice to treat…

December
13
2021

The Dermatology Digest – Superficial Radio Therapy Clinical Benefits and Studies

Not all treatment modalities for non-melanoma skin cancer are the same. In Part 2 of this video series, Dr. Mark Nestor discusses studies that demonstrate the clinical benefits of SRT, including cure rate, cosmesis, and…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry